Effect of Inferior Alveolar and Gow-Gates Nerve Block Techniques for Symptomatic Mandibular Molars
NCT ID: NCT03117491
Last Updated: 2017-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
150 participants
INTERVENTIONAL
2015-12-01
2016-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anesthetic Efficacy of Gow-Gates Versus Conventional Inferior Alveolar Nerve Block Techniques
NCT01329874
Efficacy of Two Injection Techniques on Success Rate of Inferior Alveolar Nerve Anesthesia
NCT02543619
Efficacy of Combining an Inferior Alveolar Nerve Block With a Buccal Infiltration
NCT06276842
The Effect of Intra-pulpal Anesthesia With Cryotherapy on Intra-operative Pain
NCT06194721
Anesthetic Efficacy of X-tip Intraosseous Injection
NCT01214369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GGNB injection technique
In GGNB group, every patient received two1.8-mL cartridges of 2% lidocaine with 1:80,000 epinephrine using the GGNB technique
GGNB injections
The patients received two GGNB injections of 1.8 mL 2% lidocaine with 1:100,000 epinephrine
IANB injection technique
In IANB group, every patient received two 1.8-mL cartridges of 2% lidocaine with 1:80,000 epinephrine using the IANB technique
IANB injections
The patients received two IANB injections of 1.8 mL 2% lidocaine with 1:100,000 epinephrine
GGNB + IANB injection technique
In IANB + GGNB group, every patient received one 1.8-mL cartridges of 2% lidocaine with 1:80,000 epinephrine using the IANB technique and one 1.8-mL cartridges of 2% lidocaine with 1:80,000 epinephrine using the GGNB technique
GGNB + IANB injections
The patients received one GGNB injection plus one IANB injection of 1.8 mL 2% lidocaine with 1:100,000 epinephrine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GGNB injections
The patients received two GGNB injections of 1.8 mL 2% lidocaine with 1:100,000 epinephrine
IANB injections
The patients received two IANB injections of 1.8 mL 2% lidocaine with 1:100,000 epinephrine
GGNB + IANB injections
The patients received one GGNB injection plus one IANB injection of 1.8 mL 2% lidocaine with 1:100,000 epinephrine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of symptomatic irreversible pulpitis
Exclusion Criteria
* history of significant medical conditions
* allergies to local anesthetics or sulfites
* pregnancy
* taking any medications that might influence anesthetic assessment
* active sites of pathosis in area of injection
* inability to give informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isfahan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Masoud Saatchi, DDS MSc
Professor of Endodontics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Isfahan University of Medical Sciences
Isfahan, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
395437
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.